Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Go back to Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.00 -0.13 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.13 | 52 Week High | $9.23 | |||
| Open | $9.16 | 52 Week Low | $1.16 | |||
| Day High | $9.37 | P/E | N/A | |||
| Day Low | $8.97 | EPS | $-0.30 | |||
| Volume | 3,692,821 | |||||

